Novus International, Inc. has been selected to receive the 2012 North
American New Product Innovation Award in Prebiotics for PREVIDA®.
The award is presented by Frost & Sullivan, a 50-year old global
market research organization of 1,800 analysts and consultants who
monitor more than 300 industries and 250,000 companies.
“Novus is proud to receive the New Product Innovation award from
Frost & Sullivan,” stated Thad Simons, President and CEO, at Novus.
“We’re equally humbled by this recognition because our mission is not to
seek awards for what we do; rather it is to focus on sustainably
meeting the growing global need for health and nutrition. We’re excited
about offering our customers the health and nutrition solutions
associated with feeding PREVIDA.”
Frost & Sullivan’s selection of PREVIDA was the result of a
decision support matrix (DSM) comprised of five criteria, including 1)
Innovative Element of the Product, 2) Leverage of Leading-Edge
Technologies, 3) Value Added Features/Benefits, 4) Increased Customer
ROI and 5) Customer Acquisition/Penetration Potential. Frost &
Sullivan concluded that PREVIDA was truly an innovative product with
immense market penetration potential.
Frost & Sullivan’s research philosophy originates with the CEO’s
360-Degree Perspective™, which serves as the foundation of its TEAM
Research™ methodology. “This unique approach enables us to determine how
best-in-class companies worldwide manage growth, innovation and
leadership,” noted Aarthi Janakiraman, Senior Research Analyst at Frost
& Sullivan. “Based on the findings of this Best Practice research,
we’re delighted to present the 2012 North American New Product
Innovation Award in Prebiotics for Animal Health to Novus.”
PREVIDA is a unique prebiotic comprised of an all-natural,
hemicellulose extract that promotes intestinal health for a variety of
aquatic species. The product contains a high level of soluble dietary
fiber in the form of specific oligosaccharides, which have been shown to
provide compelling digestive health benefits. Studies suggest PREVIDA
impacts gut microflora and optimizes immune response leading to
healthier, more resilient shrimp and fish.
PREVIDA was discovered by research scientists at Temple-Inland, a
wood products company. After Temple-Inland assessed the nutritional
profile and health benefits of the product, they reached out to Novus
for its expertise in developing animal health and nutrition solutions.
Novus has the exclusive global marketing and distribution rights for
PREVIDA.
“PREVIDA is the first real alternative to MOS,” said Dr. Francisco S.
Gomes, Executive Manager Aqua Business Unit, at Novus. “For years the
industry has consistently reduced the inclusion rates of MOS looking for
a cost benefit. PREVIDA offers this cost benefit because it is a
holistic solution.”
